Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix

Yang Guo1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and

Ting Zhong1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and

Xiao-Chuan Duan1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and

Shuang Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and

Xin Yao1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and

Yi-Fan Yin1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and

Dan Huang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and

Wei Ren1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and

Qiang Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and ;3 State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China

Xuan Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and Correspondence[email protected]

show all

Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix

Citations (20)

Read on this site (4)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date